Regeneron stock has trended bearishly since August, but growth in LIBTAYO and DUPIXENT offers a promising outlook, prompting a BUY rating. EYLEA HD's success mitigates biosimilar competition, ...

A common, over-the-counter form of vitamin B3 has emerged as an inexpensive ally in protecting us from skin cancer, lowering the risk by an average of 14% and increasing to a massive 54% for anyone ...

Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients with Merkel cell carcinoma after surgery. Though recurrence rates overall ...

Sunbathing is tan-talizing — but it comes at a price. Skin cancer is the most common cancer in the US — and one of the most preventable. Overexposure to ultraviolet (UV) radiation from the sun or ...

A form of B3 called nicotinamide cut the risk of developing repeat skin cancers by as much as 54 percent, according to new research. A large new study found that nicotinamide, a form of vitamin B3, ...

Nicotinamide significantly reduces new skin cancer risk, especially when started early, with a 54% reduction after a first diagnosis. The study's findings align with previous trials, reinforcing ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. A new study found nicotinamide supplements may cut the ...